Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs: A report from the Swiss Blood Stem Cell Transplantation and Cellular Therapy Group

AIM: Until the year 2000, allogeneic haematopoietic cell transplantation (HCT) was the standard treatment for young and fit chronic myeloid leukaemia (CML) patients. CML was the main indication for allogeneic HCT. The introduction of tyrosine kinase inhibitors changed the treatment of CML patients d...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Swiss medical weekly 2024-05, Vol.154 (5), p.3754
Hauptverfasser:	Heim, Dominik, Baldomero, Helen, Medinger, Michael, Masouridi-Levrat, Stavroula, Schanz, Urs, Nair, Gayathri, Güngör, Tayfun, Halter, Jörg, Passweg, Jakob R., Chalandon, Yves, Swiss Stem Cell Transplantation Group (SBST)
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!